Table I.

Clinical, echocardiographic and baseline variables, procedural variables, and immediate and mid-term outcomes.

Case no.	Age, years/sex	NYHA class	Associated diseases	Defect location	Defect size by ECHO, inner/outer opening, mm	Closure device size, mm	Device supplier	Operation time, min	Residual shunt at discharge/follow-up	AR at discharge/ follow-up	NYHA class at follow-up
1	24/M	II	None	NCS to RA	9/5	VSD16	Memory	70	Middle/none	Small/small	I
2	50/M	II	VSD	NCS to RA	8/4	VSD12	Memory	55	None/none	Small/small	I
3	28/F	III	None	NCS to RA	10/7	VSD16	Huayi	60	None/none	None/small	I
4	27/F	III	None	NCS to RA	8.7/5.7	VSD14	Memory	90	None/none	None/none	I
5	43/M	IV	AF	NCS to RA	9/4.5	VSD16	Huayi	85	None/none	None/small	II
6	40/M	II	HTN	NCS to RA	7/4	VSD12	Memory	40	None/none	Small/none	I
7	35/M	III	None	NCS to RA	10/4.4	VSD16	Memory	30	None/none	None/none	I
8	48/M	II	None	NCS to RA	10/4.6	VSD16	Memory	50	None/none	Middle/small	I
9	66/F	II	PFO, VSD	NCS to RV	5/3	VSD14	Memory	75	None/none	None/small to middle	I
10	48/F	III	None	RCS to RA	7.2	VSD10	Memory	65	None/none	None/small	I
11	51/M	II	None	RCS to RA	10/7	VSD16	Huayi	45	None/none	None/small	I
12	23/M	II	None	RCS to RA	7/5.6	VSD16	Huayi	80	None/none	None/none	I
13	23/M	II	None	NCS to RA	8/5	VSD14	Huayi	60	None/none	None/none	I
14	31/M	II	PFO	NCS to RA	11/6	VSD16	Huayi	45	None/none	None/none	I

M, male; F, female; NYHA, New York Heart Association; ECHO, echocardiography; AR, aortic regurgitation; NCS, non-coronary sinus; RCS, right coronary sinus; RA, right atrium; RV, right ventricle; VSD, ventricular septal defect; AF, atrial fibrillation; HTN, hypertension; PFO, patent foramen ovale; Huayi, Beijing Huayishengjie Technology Co., Ltd.; Memory, Shanghai Shape Memory Co., Ltd.